CR10067A - PRESERVATION AND / OR PERFUSION OF BODIES - Google Patents

PRESERVATION AND / OR PERFUSION OF BODIES

Info

Publication number
CR10067A
CR10067A CR10067A CR10067A CR10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A CR 10067 A CR10067 A CR 10067A
Authority
CR
Costa Rica
Prior art keywords
organ
perfusion
preservation
solution
bodies
Prior art date
Application number
CR10067A
Other languages
Spanish (es)
Inventor
Lindon Young
Original Assignee
Philadelphia College Of Osteopathic Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/341,654 external-priority patent/US7326353B2/en
Application filed by Philadelphia College Of Osteopathic Medicine filed Critical Philadelphia College Of Osteopathic Medicine
Publication of CR10067A publication Critical patent/CR10067A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Solución de preservación, perfusión y/o reperfusión de un órgano, en especial el corazón, para transplantes. La solución contiene inhibidores de péptidos de proteína quinasa C E (PKC e). También se describen métodos para usar la solución de la invención, incluyendo métodos de preservación de un órgano para transplante, de protección de un órgano después de una isquemia, de mantenimiento de liberación de óxido nítrico y/o de liberación de superóxido en un órgano isquémico y de protección de un órgano contra los daños ocasionados cuando está aislado del sistema circulatorio.Preservation, perfusion and / or reperfusion solution of an organ, especially the heart, for transplants. The solution contains C E protein kinase peptide inhibitors (PKC e). Methods for using the solution of the invention are also described, including methods of preserving an organ for transplantation, of protecting an organ after an ischemia, of maintaining nitric oxide release and / or superoxide release in an ischemic organ. and protection of an organ against damage caused when it is isolated from the circulatory system.

CR10067A 2005-12-09 2008-06-12 PRESERVATION AND / OR PERFUSION OF BODIES CR10067A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74864505P 2005-12-09 2005-12-09
US11/341,654 US7326353B2 (en) 2001-11-27 2006-01-30 Methods for reclaiming developing solvents

Publications (1)

Publication Number Publication Date
CR10067A true CR10067A (en) 2008-10-10

Family

ID=39324885

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10067A CR10067A (en) 2005-12-09 2008-06-12 PRESERVATION AND / OR PERFUSION OF BODIES

Country Status (6)

Country Link
JP (1) JP2009521410A (en)
AU (1) AU2006349615B2 (en)
CA (1) CA2632777C (en)
CR (1) CR10067A (en)
DK (1) DK2056851T3 (en)
WO (1) WO2008051247A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013916A1 (en) * 1999-08-20 2001-03-01 Sagami Chemical Research Center Drugs inhibiting cell death
US20020168354A1 (en) * 2000-11-10 2002-11-14 Daria Mochly-Rosen psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
WO2002057413A2 (en) * 2001-01-18 2002-07-25 The Board Of Trustees Of The Leland Stanford Junior University Peptides for activation and inhibition of delta pkc
EP2228069A1 (en) * 2003-09-16 2010-09-15 Garvan Institute Of Medical Research Antagonists of protein kinase c-epsilon (pkcepsilon) and their use for the treatment of aberrant glucose metabolism associated therewith.
CA2549052A1 (en) * 2003-12-11 2005-06-30 The Board Of Trustees Of The Leland Stanford Junior University Isozyme-specific antagonists of protein kinase c
US7691861B2 (en) * 2004-01-19 2010-04-06 Novartis Ag Indolymaleimide derivatives
US7265092B2 (en) * 2004-09-30 2007-09-04 Kai Pharmaceuticals, Inc. Pharmaceutical formulation
US20060160062A1 (en) * 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs

Also Published As

Publication number Publication date
AU2006349615B2 (en) 2012-09-20
WO2008051247A1 (en) 2008-05-02
AU2006349615A1 (en) 2008-05-02
CA2632777A1 (en) 2008-05-02
JP2009521410A (en) 2009-06-04
CA2632777C (en) 2019-08-20
DK2056851T3 (en) 2013-10-14

Similar Documents

Publication Publication Date Title
CR9250A (en) SOLUTION FOR PERFUSION AND / OR PRESERVATION OF ORGANS
AR084378A1 (en) COMBINATIONS OF ACTIVE COMPOUNDS
MX2021005012A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION OF COMPOUNDS AND THEIR USE AS INHIBITORS OF ATR KINASE.
CL2022003733A1 (en) 1'-cyano nucleoside analogues and uses thereof
MX2010003291A (en) Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells.
PE20090228A1 (en) SULFUR COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS SERINE PROTEASE NS3
EA200701660A1 (en) COMPOSITIONS AND METHODS INTENDED FOR THE RETAILED STORAGE OF ERYTHROCYTES
CL2017000998A1 (en) Composition comprising a biological control agent of the species bacillus subtilis and a fungicide of the group of inhibitors of mitosis and cell division, such as fenamidone. (divisional application 3272-2014)
ES2571104T3 (en) Stabilization of RNA and extraction of RNA present in intact cells within a blood sample
CU23751B7 (en) CARBONILAMINO PIRROLOPIRAZOLES, POWERFUL INHIBITORS OF QUINASA
MX2009011002A (en) Ischemia/reperfusion protection compositions and methods of using.
DOP2025000244A (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
CL2010001633A1 (en) Compounds derived from benzoxazine and benzothiazine, nos inhibitors; pharmaceutical composition that includes them; and its use in the treatment of headache, neuropathic, inflammatory, visceral pain, neuroinflammation, hyperalgesia, allodynia, among others.
WO2008089103A8 (en) Targeting ncca-atp channel for organ protection following ischemic episode
TR201900937T4 (en) Method for preserving organs and tissues.
EA201890045A1 (en) COMBINED COMPOSITIONS FOR THE TREATMENT OF DISTURBANCES, WHICH ARE REQUIRED TO ELIMINATE OR DESTRUCTION OF UNDESIRABLE CELL PROLIFERATES
PE20091164A1 (en) MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE
CL2013003307A1 (en) Agent comprising ciazofamide or fenamidone; and its use to treat mycosis in fish and invertebrates in all stages of development caused by fungi of the saprolegnia, achlya and aphanomyces genera (div.sol.no 1056-08).
CO2021015130A2 (en) bnip3 peptides for the treatment of reperfusion injury
AR039819A1 (en) PROTECTIVE SOLUTION TO AVOID ISCHEMICAL DAMAGES IN ORGANS
WO2004060321A3 (en) Cardioprotective delta opioid receptor agonists and methods of using same
CR10067A (en) PRESERVATION AND / OR PERFUSION OF BODIES
BRPI0619561B8 (en) method of preserving an organ for transplantation, protecting an ischemic organ, attenuating organ dysfunction after ischemia, or protecting an organ from damage after isolation from the circulatory system and a solution comprising at least one peptide protein kinase inhibitor
MX2016015635A (en) Methods and compositions for preventing ischemia reperfusion injury in organs.
WO2016127123A3 (en) Compounds and methods for preventing or treating sensory hair cell death

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)